These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 17409887)

  • 1. Management of unresected stage III non-small cell lung cancer: a systematic review.
    Okawara G; Mackay JA; Evans WK; Ung YC;
    J Thorac Oncol; 2006 May; 1(4):377-93. PubMed ID: 17409887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.
    Okawara G; Rusthoven J; Newman T; Findlay B; Evans W
    Cancer Prev Control; 1997 Aug; 1(3):249-59. PubMed ID: 9765750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second-line or subsequent systemic therapy for recurrent or progressive non-small cell lung cancer: a systematic review and practice guideline.
    Noble J; Ellis PM; Mackay JA; Evans WK;
    J Thorac Oncol; 2006 Nov; 1(9):1042-58. PubMed ID: 17409993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Weekly paclitaxel and carboplatin with concurrent three dimensional conformal radiotherapy for locally advanced non small cell lung cancer].
    Wang J; Pang QS; Wang P; Wang J; Wang W
    Zhonghua Zhong Liu Za Zhi; 2007 Oct; 29(10):769-72. PubMed ID: 18396691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined modality therapy of non-small cell lung cancers.
    Juretic A; Sobat H; Samija M
    Ann Oncol; 1999; 10 Suppl 6():93-8. PubMed ID: 10676559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of a novel protocol of combined induction chemotherapy and concurrent chemoradiation in unresected non-small-cell lung cancer: a ten-year experience with vinblastine, Cisplatin, and radiation therapy.
    Waters E; Dingle B; Rodrigues G; Vincent M; Ash R; Dar R; Inculet R; Kocha W; Malthaner R; Sanatani M; Stitt L; Yaremko B; Younus J; Yu E
    Clin Lung Cancer; 2010 Jul; 11(4):243-50. PubMed ID: 20630826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Taxanes as first-line therapy for advanced non-small cell lung cancer: a systematic review and practice guideline.
    Chu Q; Vincent M; Logan D; Mackay JA; Evans WK;
    Lung Cancer; 2005 Dec; 50(3):355-74. PubMed ID: 16139391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer.
    Fried DB; Morris DE; Poole C; Rosenman JG; Halle JS; Detterbeck FC; Hensing TA; Socinski MA
    J Clin Oncol; 2004 Dec; 22(23):4837-45. PubMed ID: 15570087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group.
    Segawa Y; Ueoka H; Kiura K; Kamei H; Tabata M; Sakae K; Hiraki Y; Kawahara S; Eguchi K; Hiraki S; Harada M
    Br J Cancer; 2000 Jan; 82(1):104-11. PubMed ID: 10638975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined modality treatment of non-small-cell lung cancer.
    Westeel V; Depierre A
    Am J Respir Med; 2003; 2(6):477-90. PubMed ID: 14719987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodality therapy in unresected stage III non-small cell lung cancer: the American Cooperative Groups' Experience.
    Green MR
    Lung Cancer; 1995 Apr; 12 Suppl 1():S87-94. PubMed ID: 7551938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck.
    Budach W; Hehr T; Budach V; Belka C; Dietz K
    BMC Cancer; 2006 Jan; 6():28. PubMed ID: 16448551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group.
    Logan DM; Lochrin CA; Darling G; Eady A; Newman TE; Evans WK
    Cancer Prev Control; 1997 Dec; 1(5):366-78. PubMed ID: 9765759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of radiation dose and chemotherapy on overall survival in 237 patients with Stage III non-small-cell lung cancer.
    Wang L; Correa CR; Zhao L; Hayman J; Kalemkerian GP; Lyons S; Cease K; Brenner D; Kong FM
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1383-90. PubMed ID: 18929449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A meta-analysis of the timing of chest irradiation in the combined modality treatment of limited-stage small cell lung cancer.
    Huncharek M; McGarry R
    Oncologist; 2004; 9(6):665-72. PubMed ID: 15561810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy plus radiotherapy compared with radiotherapy alone in the treatment of locally advanced, unresectable, non-small-cell lung cancer. A meta-analysis.
    Pritchard RS; Anthony SP
    Ann Intern Med; 1996 Nov; 125(9):723-9. PubMed ID: 8929005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of stage III non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
    Ramnath N; Dilling TJ; Harris LJ; Kim AW; Michaud GC; Balekian AA; Diekemper R; Detterbeck FC; Arenberg DA
    Chest; 2013 May; 143(5 Suppl):e314S-e340S. PubMed ID: 23649445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined modality treatment for stage III non-small cell lung cancer.
    Bonomi P
    Lung Cancer; 1995 Jun; 12 Suppl 2():S41-52. PubMed ID: 7551949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I study of concurrent chemoradiation with pemetrexed and cisplatin followed by consolidation pemetrexed for patients with unresectable stage III non-small cell lung cancer.
    Cardenal F; Arnaiz MD; Morán T; Jové J; Nadal E; Porta R; Solé JM; Brao I; Palmero R; Fuentes R; Núñez I; Caveda E; Cassinello A
    Lung Cancer; 2011 Oct; 74(1):69-74. PubMed ID: 21353323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-chemotherapy gross tumor volume is predictive of survival in patients with stage III non-small cell lung cancer treated with combined modality therapy.
    Stinchcombe TE; Morris DE; Moore DT; Bechtel JH; Halle JS; Mears A; Deschesne K; Rosenman JG; Socinski MA
    Lung Cancer; 2006 Apr; 52(1):67-74. PubMed ID: 16499996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.